CINECA IRIS Institutional Research Information System

VASILE, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.936
AS - Asia 1.450
EU - Europa 1.199
SA - Sud America 260
AF - Africa 145
Continente sconosciuto - Info sul continente non disponibili 98
OC - Oceania 3
Totale 6.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.851
SG - Singapore 524
IT - Italia 420
CN - Cina 342
HK - Hong Kong 224
SE - Svezia 208
BR - Brasile 205
VN - Vietnam 170
GB - Regno Unito 109
DE - Germania 106
CI - Costa d'Avorio 79
FR - Francia 73
BG - Bulgaria 64
AT - Austria 54
CA - Canada 43
RU - Federazione Russa 40
IN - India 33
JP - Giappone 30
FI - Finlandia 26
BD - Bangladesh 24
PL - Polonia 23
NL - Olanda 21
TR - Turchia 21
AR - Argentina 19
MX - Messico 19
SN - Senegal 18
NG - Nigeria 16
ES - Italia 14
IQ - Iraq 14
PK - Pakistan 13
UA - Ucraina 10
ID - Indonesia 8
VE - Venezuela 8
EC - Ecuador 7
CR - Costa Rica 6
KE - Kenya 6
MA - Marocco 6
MY - Malesia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
CO - Colombia 5
LT - Lituania 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CL - Cile 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
KR - Corea 4
PE - Perù 4
TN - Tunisia 4
EG - Egitto 3
HN - Honduras 3
IL - Israele 3
IR - Iran 3
PA - Panama 3
RO - Romania 3
BE - Belgio 2
BY - Bielorussia 2
BZ - Belize 2
DK - Danimarca 2
HU - Ungheria 2
JO - Giordania 2
PH - Filippine 2
PR - Porto Rico 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
DO - Repubblica Dominicana 1
EU - Europa 1
FJ - Figi 1
GD - Grenada 1
GY - Guiana 1
IE - Irlanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 5.994
Salva come PNG Salva come JPEG
Città #
Ashburn 365
Singapore 259
Hong Kong 218
Chandler 187
Fairfield 183
Santa Clara 179
Dallas 178
San Jose 175
Woodbridge 150
Houston 123
Shanghai 88
New York 86
Beijing 80
Abidjan 79
Seattle 79
Ann Arbor 74
Los Angeles 71
Wilmington 64
Sofia 63
Boardman 60
Cambridge 60
Milan 60
Serra 56
London 55
Vienna 48
Munich 47
Council Bluffs 43
Ho Chi Minh City 43
Florence 41
Princeton 40
Lawrence 36
Lauterbourg 32
Hanoi 30
Pisa 27
Medford 26
Rome 24
Buffalo 23
Frankfurt am Main 23
Tokyo 21
Ottawa 19
Dakar 18
San Diego 17
Des Moines 16
Lagos 16
Warsaw 16
Redondo Beach 15
Istanbul 14
Ogden 14
Orem 13
São Paulo 13
Chicago 12
Da Nang 12
Dong Ket 11
Fuzhou 11
Helsinki 11
Turku 11
Düsseldorf 10
Kent 10
Nuremberg 10
Paris 10
Phoenix 10
Dearborn 9
Lancaster 9
Toronto 9
Baghdad 8
Belo Horizonte 8
Boulder 8
Bremen 8
Denver 8
Mexico City 7
Montreal 7
Nanjing 7
Vicopisano 7
Chennai 6
Kunming 6
Poplar 6
Quanzhou 6
Redwood City 6
Stockholm 6
Bari 5
Haiphong 5
Hyderabad 5
Jiaxing 5
Lucca 5
Nairobi 5
Philadelphia 5
Portsmouth 5
Amsterdam 4
Atlanta 4
Brooklyn 4
Bắc Ninh 4
Casablanca 4
Guangzhou 4
Itaquaquecetuba 4
Jakarta 4
Manaus 4
Manchester 4
Memphis 4
Naples 4
Norwalk 4
Totale 4.008
Salva come PNG Salva come JPEG
Nome #
Pancreatic resections for metastases: A twenty-year experience from a tertiary care center 210
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 206
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 204
Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care 200
Pre-treatment EGFR-T790M subclones in lung adenocarcinoma harboring activating mutation of EGFR: a positive prognostic factor for survival? 196
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 191
HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer 190
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 189
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 184
Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer. 182
First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors 182
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine 177
Ampullary adenocarcinomas: The immunohistochemical score of CDX2, CK7 and CK 20 identify pathological subtypes and their prognosis 171
Lights and shadows of molecular pathology and immunotherapy in adjuvant setting of patients with pancreatic ductal adenocarcinoma: Tumor volume and microsatellite instability inversely affect early progression free survival 170
Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer service 169
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 166
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 163
Immune checkpoint inhibitors in esophageal cancers: Are we finally finding the right path in the mist? 161
First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age? 156
MICROSATELLITE INSTABILITY AND TUMOR VOLUME INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 151
Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer 151
Robotic Versus Open Pancreatoduodenectomy With Vein Resection and Reconstruction: A Propensity Score-Matched Analysis 146
Adjuvant radiotherapy in patients with pancreatic adenocarcinoma. Is it still appealing in clinical trials? A meta-analysis and review of the literature 144
Comment on: 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: An AGEO prospective multicentre cohort' 142
Feasibility of BRCA1/2 testing of formalin-fixed and paraffin-embedded pancreatic tumor samples: A consecutive clinical series 141
Baseline computed-tomography (CT)-evaluated sarcopenia predicts toxicity from first-line chemotherapy in metastatic gastric cancer (mGC) patients 140
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab 137
IDENTIFICATION OF PATHOLOGICAL AMPULLARY ADENOCARCINOMAS SUBTYPES AND THEIR PROGNOSIS USING THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 129
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer 125
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 116
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules 115
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: Clinics and pathology are not enough 113
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 112
Combination chemotherapy in patients with advanced pancreatic cancer with an eastern cooperative oncology group performance status of 2: Lights and shadows of a frail route 102
FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer 97
ROS1 rearrangements are uncommon in biliary tract cancers 91
Gastric cancer: Translating novels concepts into clinical practice 86
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study 86
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer 84
Second-line chemotherapy in advanced biliary cancer: The present now will later be past 81
Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution 71
Stomach preservation in pancreatectomy with celiac axis resection: Prediction and technique via Mayo Clinic classification 64
Totale 6.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022355 0 0 7 10 54 84 14 9 12 29 31 105
2022/2023770 69 134 65 36 89 73 4 56 160 7 64 13
2023/2024431 28 30 73 32 44 69 34 7 10 15 43 46
2024/20251.408 9 51 28 85 128 176 80 59 158 181 173 280
2025/20261.768 157 186 204 215 222 122 266 69 98 144 56 29
2026/2027233 56 100 77 0 0 0 0 0 0 0 0 0
Totale 6.091